Chen C-Y, Liu C-J, Feng J-Y, Loong C-C, Liu C, Hsia C-Y, Hu L-Y, Lin N-C, Hu Y-W, Yeh C-M, Chen T-J, Yang C-C
Division of Transplantation Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
Institute of Public Health, National Yang-Ming University, Taipei, Taiwan.
Am J Transplant. 2015 Aug;15(8):2180-7. doi: 10.1111/ajt.13235. Epub 2015 Apr 14.
Morbidity and mortality from tuberculosis (TB) are high in Taiwan. We conducted a nationwide population-based matched cohort study using data retrieved from the Taiwan's National Health Insurance Research Database to determine the impact of TB after liver transplantation (LT). During 2000-2011, we identified 3202 liver transplant recipients and selected subjects from the general population matched for age, sex, and comorbidities on the same index date of recognition of LT with a 1:10 ratio. The data were analyzed using Cox proportional hazards models. Compared to the matched cohort, liver transplant patients had a higher risk for TB (adjusted HR 2.25, 95% CI 1.65-3.05, p < 0.001), and those with TB showed higher mortality (HR 2.27, 95% CI 1.30-3.97, p = 0.004). Old age (HR 2.64, 95% CI 1.25-5.54, p = 0.011) and mammalian target of rapamycin inhibitors (mTORis) (HR 3.09, 95% CI 1.68-5.69, p < 0.001) were significant risk factors for TB in LT; mTORis were also associated with mortality after adjusting for confounders (HR 2.13, 95% CI 1.73-2.62, p < 0.001). Therefore, regular surveillance of TB and treatment of latent TB infection in high-risk patients after LT are important, especially in TB-endemic areas.
台湾地区结核病(TB)的发病率和死亡率很高。我们利用从台湾全民健康保险研究数据库中检索到的数据,开展了一项基于全国人群的配对队列研究,以确定肝移植(LT)后结核病的影响。在2000年至2011年期间,我们确定了3202名肝移植受者,并从普通人群中选择了年龄、性别和合并症相匹配的受试者,在肝移植确认的同一索引日期按1:10的比例进行配对。使用Cox比例风险模型对数据进行分析。与配对队列相比,肝移植患者患结核病的风险更高(调整后的风险比[HR]为2.25,95%置信区间[CI]为1.65 - 3.05,p < 0.001),且结核病患者的死亡率更高(HR为2.27,95% CI为1.30 - 3.97,p = 0.004)。高龄(HR为2.64,95% CI为1.25 - 5.54,p = 0.011)和雷帕霉素靶蛋白抑制剂(mTORis)(HR为3.09,95% CI为1.68 - 5.69,p < 0.001)是肝移植中结核病的显著危险因素;在调整混杂因素后,mTORis也与死亡率相关(HR为2.13,95% CI为1.73 - 2.62,p < 0.001)。因此,对肝移植后高危患者进行结核病的定期监测和潜伏性结核感染的治疗很重要,尤其是在结核病流行地区。